Testing effectiveness (Phase 2)Ended earlyNCT04541628
What this trial is testing
Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A
Who this might be right for
Hemophilia A
Eli Lilly and Company 3
Showing 4 of 4 results